Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Week In Review: China Pharmas Announce Deals Worth $1.5 Billion
Article By:
ChinaBio® Today
Saturday, December 8, 2018 4:21 PM EST
WuXi AppTec, China's largest CRO/CMO, completed a $1 billion IPO on the Hong Kong markets, pricing the offering in the middle of the expected range (see story). In May, WuXi became a public company by completing a $328 million IPO in Shanghai.
Revance Fails Phase 3 Trial; Shares Down 24% In After-Hours
Article By:
Terry Chrisomalis
Tuesday, June 14, 2016 3:10 AM EST
The phase 3 trial was using the company's drug RT001 to treat patients with lateral canthal lines, or Crows Feet. The drug in question is a topical gel that would be easier to administer in areas of the body that are very sensitive.
In this article: RVNC
Five Biotech Stocks That Doubled In 2015
Article By:
Zacks Investment Research
Friday, January 8, 2016 5:10 AM EST
It’s been a roller-coaster ride for the biotech sector in 2015, with several stocks seeing major highs and lows as the year progressed. The year will continue to see mergers and acquisitions and licensing and collaboration deals being signed.
Revance Announces Positive Phase 2 Results In Anti-Wrinkle Study
Article By:
Terry Chrisomalis
Thursday, October 29, 2015 2:29 PM EST
Revance announces positive phase 2 results in anti-wrinkle study; Shares are up 30%.
In this article: RVNC